Search | La Lingua Nostra

added article Home

2025-08-26 18:07:43 -

U.S. Gout Therapeutics Market Forecast: Clinical Pipeline and Long-Term Growth Opportunities

The U.S. gout therapeutics market, valued at USD 1.40 billion in 2024, is anticipated to expand at a CAGR of 6.9% from 2025 to 2034, with growth increasingly driven by segment-wise performance across product types, treatment phases, and therapeutic platforms. The market can be segmented by product type into urate-lowering therapies (ULTs), anti-inflammatory agents, and emerging biologics, with...

0 Comments 0 Shares 20 Views 0 Reviews